Acridinyl Anisidide

Also known as: Amsacrine

Therapeutic indications

Acridinyl Anisidide is indicated for:

Population group: both men and women, only adults (18 years old or older)

Acute myeloid leukaemia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Acridinyl Anisidide is contraindicated in the following cases:

at least one of

Leukopenia

Pregnancy